Getting a rarer perspective
When investigating the potential of using a social impact bond to fund generic drug repurposing for rare diseases, Findacure’s Rick Thompson conducted a series of focus groups with rare disease patients.
He explains the challenges they face and how valuing them and their input can be mutually beneficial in his article in Deep Dive: Patient centricity. Read the full article here.
Coming soon: Deep Dive: Oncology. Read more about Deep Dive and sign up to receive complimentary copies here.